Insider Transactions in Q1 2025 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2025
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,288
-4.24%
|
$199,320
$15.5 P/Share
|
|
Feb 10
2025
|
Keith A. Goldan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,777
-4.0%
|
$56,655
$15.5 P/Share
|
|
Feb 10
2025
|
Neil Gallagher President, Head of R&D |
SELL
Open market or private sale
|
Direct |
4,618
-5.15%
|
$69,270
$15.5 P/Share
|
|
Feb 05
2025
|
Neil Gallagher President, Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
41,900
+21.25%
|
-
|
|
Feb 05
2025
|
Aleksandra Rizo |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Feb 05
2025
|
Dennis Podlesak |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.68%
|
-
|
|
Feb 05
2025
|
Michael A Metzger Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149,500
+21.68%
|
-
|
|
Feb 05
2025
|
Keith A. Goldan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,900
+20.24%
|
-
|
|
Feb 05
2025
|
Jennifer Jarrett |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.74%
|
-
|
|
Feb 05
2025
|
Keith Katkin |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.74%
|
-
|
|
Feb 05
2025
|
William Meury |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.74%
|
-
|
|
Feb 05
2025
|
Pierre Legault |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.74%
|
-
|
|
Feb 05
2025
|
Martin H. Huber Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+25.25%
|
-
|